MERCK ALZHEIMER DRUG ENTERS PHASE II TRIAL December 4, 2012 By Angela Merck & Co has developed a new drug for the treatment of Alzheimer Disease. It has the potential to limit production of a protein that is commonly thought to be the cause of the disease. For further reading …..